JP2024543952A5 - - Google Patents
Info
- Publication number
- JP2024543952A5 JP2024543952A5 JP2024532316A JP2024532316A JP2024543952A5 JP 2024543952 A5 JP2024543952 A5 JP 2024543952A5 JP 2024532316 A JP2024532316 A JP 2024532316A JP 2024532316 A JP2024532316 A JP 2024532316A JP 2024543952 A5 JP2024543952 A5 JP 2024543952A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- aso
- prerna
- pharmaceutical composition
- mir17hg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163284527P | 2021-11-30 | 2021-11-30 | |
| US63/284,527 | 2021-11-30 | ||
| PCT/US2022/080563 WO2023102377A2 (en) | 2021-11-30 | 2022-11-29 | Antisense inhibitors of mir17hg pre-rna as therapeutic agents in cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543952A JP2024543952A (ja) | 2024-11-26 |
| JP2024543952A5 true JP2024543952A5 (https=) | 2025-12-09 |
Family
ID=86613147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532316A Pending JP2024543952A (ja) | 2021-11-30 | 2022-11-29 | がんにおける治療剤としてのｍｉｒ１７ｈｇプレｒｎａのアンチセンス阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240352462A1 (https=) |
| EP (1) | EP4441227A2 (https=) |
| JP (1) | JP2024543952A (https=) |
| KR (1) | KR20240112333A (https=) |
| CN (1) | CN118339292A (https=) |
| AU (1) | AU2022402987A1 (https=) |
| CA (1) | CA3238432A1 (https=) |
| WO (1) | WO2023102377A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117384903A (zh) * | 2023-10-23 | 2024-01-12 | 中国农业科学院兰州畜牧与兽药研究所 | 一种牦牛Lnc4047基因及其应用 |
| CN120789090B (zh) * | 2025-09-04 | 2025-11-28 | 核工业总医院 | U2surp在制备弥漫大b细胞淋巴瘤治疗药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1939286A4 (en) * | 2005-07-29 | 2009-05-20 | Kyowa Hakko Kirin Co Ltd | NEW PEPTIDE |
| EP3388068A1 (en) * | 2011-06-21 | 2018-10-17 | Alnylam Pharmaceuticals, Inc. | Composition and methods for inhibition of expression of protein c (proc) genes |
| US9862943B1 (en) * | 2013-06-27 | 2018-01-09 | California Institute Of Technology | Long noncoding RNAs and cell reprogramming and differentiation |
| EP3230454A1 (en) * | 2014-12-09 | 2017-10-18 | Pierfrancesco Tassone | Inhibitors of mir-17-92 cluster for anti-tumor activity in multiple myeloma and other malignancies |
-
2022
- 2022-11-29 JP JP2024532316A patent/JP2024543952A/ja active Pending
- 2022-11-29 CN CN202280079655.5A patent/CN118339292A/zh active Pending
- 2022-11-29 US US18/712,843 patent/US20240352462A1/en active Pending
- 2022-11-29 WO PCT/US2022/080563 patent/WO2023102377A2/en not_active Ceased
- 2022-11-29 AU AU2022402987A patent/AU2022402987A1/en active Pending
- 2022-11-29 EP EP22902336.1A patent/EP4441227A2/en active Pending
- 2022-11-29 KR KR1020247021295A patent/KR20240112333A/ko active Pending
- 2022-11-29 CA CA3238432A patent/CA3238432A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI823866B (zh) | 用於抑制類血管生成素蛋白-3(ANGPTL3)表現的RNAi藥劑及組合物及使用方法 | |
| JP6752151B2 (ja) | 遺伝子サイレンシングにおいて低下したｏｆｆ−ｔａｒｇｅｔ効果を有するｕｎａオリゴマー | |
| TW201920227A (zh) | 用於抑制脂蛋白元C-III (APOC3)表現之RNAi試劑及組合物 | |
| JP2022501040A5 (https=) | ||
| JP7197463B2 (ja) | Ｓｍｎ２の調節のための化合物及び方法 | |
| TW202024324A (zh) | 用於抑制17β-HSD第13型(HSD17B13)表現之RNAi藥劑、其組合物及使用方法 | |
| JP2020503070A (ja) | α−１アンチトリプシン（ＡＡＴ）ＲＮＡｉ剤、ＡＡＴ ＲＮＡｉ剤を含む組成物、及び使用方法。 | |
| JP7829035B2 (ja) | アンギオテンシノゲン（ａｇｔ）タンパク質の発現を阻害する組成物及び方法 | |
| JP2021533804A5 (https=) | ||
| TW202345865A (zh) | 抑制LPA(Apo(a))蛋白表達的組合物和方法 | |
| JP2018529732A5 (https=) | ||
| TW201828996A (zh) | 用於肌肉萎縮症之外顯子跳躍寡聚物結合物 | |
| TW201828995A (zh) | 用於肌肉萎縮症之外顯子跳躍寡聚物結合物 | |
| CZ2003848A3 (cs) | Způsob léčby poruch spojených s bcl-2 za použití antisense oligomerů bcl-2 | |
| JP6771387B2 (ja) | 遺伝子サイレンシング用トランスサイレチン対立遺伝子選択的ｕｎａオリゴマー | |
| WO2023022229A1 (ja) | モルホリノ核酸を含む修飾ヘテロ核酸 | |
| JP2016513976A5 (https=) | ||
| CN113454221A (zh) | 含有三元环的双链核酸抑制剂分子 | |
| TW202321452A (zh) | 用於抑制血管生成素樣３（ａｎｇｐｔｌ３）蛋白表達的組合物和方法 | |
| TW202202153A (zh) | 用於抑制ＰＮＰＬＡ３表現之ＲＮＡｉ劑、其醫藥組成物及使用方法 | |
| JP2024543952A5 (https=) | ||
| JP2023538283A (ja) | 代謝症候群の治療のための組成物及び方法 | |
| JP2024516356A5 (https=) | ||
| JP2021521794A (ja) | 筋ジストロフィーに対するエクソンスキッピングオリゴマーおよびオリゴマーコンジュゲート | |
| JP7829478B2 (ja) | Ａｐｏｃ３関連疾患および障害の処置のための方法 |